nSaCas9 G129-hAIDx
(Plasmid
#140596)
-
PurposeIntradomain insertion of hAIDx deaminating domain at position G129 of nickase variant of Staphylococcus aureus Cas9 [D10A]
-
Depositing Lab
-
Depositing OrganizationUniversity of Tasmania
Located in Australia -
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 140596 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepcDNA3.1
- Backbone size w/o insert (bp) 5428
- Total vector size (bp) 10150
-
Vector typeMammalian Expression
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHuman Activation-Induced Cytidine Deaminase
-
Alt namehAIDx (P182X)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)4710
-
MutationP182X truncation; D10A in SaCas9
-
Entrez GeneAICDA (a.k.a. AID, ARP2, CDA2, HEL-S-284, HIGM2)
- Promoter CMV
-
Tag
/ Fusion Protein
- P2A cleavable sequence with blasticidine resistance gene fragment (C terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer aagcgaaattacattctggggctggccattggcattacatcagtgggc
- 3′ sequencing primer gtcaagagcaagaaacatcctcagattat
- (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byGenscript
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
nSaCas9 G129-hAIDx was a gift from Alex Hewitt (Addgene plasmid # 140596) -
For your References section:
Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing. Nguyen Tran MT, Mohd Khalid MKN, Wang Q, Walker JKR, Lidgerwood GE, Dilworth KL, Lisowski L, Pebay A, Hewitt AW. Nat Commun. 2020 Sep 25;11(1):4871. doi: 10.1038/s41467-020-18715-y. 10.1038/s41467-020-18715-y PubMed 32978399